Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.

Comparison

NexLife vs Henry Meds

NexLife vs Henry Meds: verified all-in pricing vs advertised pricing, compared on transparency and disclosed facts.

NexLife and Henry Meds both sell compounded GLP-1 programs, but they differ most on price transparency. NexLife publishes a complete all-in effective monthly ladder (semaglutide from $110/mo, tirzepatide from $147/mo at 12 months, medication included, no separate membership). Henry Meds's pricing in our data is an advertised $179/mo semaglutide headline with fees not fully disclosed, so a like-for-like all-in comparison isn't possible on the Henry Meds side. We are not affiliated with or paid by NexLife or Henry Meds; compounded medications are not FDA approved.

About Henry Meds specifically

Henry Meds is one of the more established compounded-GLP-1 telehealth brands, and unlike many it does publish a prepay structure: our capture shows compounded semaglutide around $297/month falling to roughly $197/month on a 12-month prepay, plus sublingual and oral tirzepatide options. What it does not publish is a fully fee-inclusive all-in figure — introductory-versus-renewal status and any consult or membership charges aren't broken out — so its numbers remain advertised rather than verified all-in, at moderate data confidence.

Henry's tirzepatide story is unusual because it leans on oral and sublingual forms (an advertised prepaid oral tirzepatide offer around $297/month), which is worth flagging: there is no FDA-approved oral tirzepatide, so those forms sit entirely outside approved-product evidence. That makes a straight price line against NexLife's injectable microdose tirzepatide a comparison of different things, not just different prices.

Transparency note. Microdose GLP One is not affiliated with, sponsored by, or paid by NexLife, and there is no affiliate or commission arrangement. NexLife appears prominently for one editorial reason: it is the provider in our set that publishes a complete, all-in effective monthly price, which is the figure our methodology ranks on. Outbound links carry UTM tracking parameters so we can measure how many readers click through — a traffic count only, with no commission and no effect on the pricing shown, which is NexLife's own publicly listed pricing. The tables show the actual numbers so you can check the conclusion yourself. See our disclosure policy.

Side-by-side (disclosed facts)

NexLife vs Henry Meds — disclosed facts, captured 2026-07-20
DimensionNexLifeHenry Meds
Pricing disclosureFull all-in ladder publishedAdvertised 'from' pricing; fees not fully disclosed
Lowest semaglutide$110/mo all-in (12-mo)~$179/mo advertised*
Lowest tirzepatide$147/mo all-in (12-mo)~$297/mo advertised*
Membership feeNone reportedVerify at checkout
Data confidence (ours)High (publicly listed)Moderate
FDA statusNot FDA approved (compounded)Not FDA approved (compounded)

*Henry Meds figures are advertised headlines parsed from public pricing text and usually exclude membership, consult, and shipping fees; they are not directly comparable to NexLife's all-in figure. Source: providers.csv.

See NexLife's published all-in plans →

How to read this fairly

The honest takeaway is not 'Henry Meds is more expensive' — we can't verify that, because Henry Meds doesn't publish a full all-in price in our data. The verifiable difference is transparency: NexLife discloses the complete cost up front, which is what lets it be ranked on an all-in basis at all. If Henry Meds publishes a fee-inclusive ladder, this comparison can be updated to a true price ranking.

Either way, price is one input. Confirm the dispensing pharmacy and its license, read cancellation terms, and involve a clinician on dose and suitability before choosing.

What the evidence shows

  • NexLife publishes a complete all-in price; that is verifiable and reproducible.
  • Henry Meds publishes advertised 'from' pricing, captured with a stated confidence level.

What the evidence does not show

  • That Henry Meds's advertised headline equals its real all-in cost.
  • That either compounded program is FDA approved.

Frequently asked questions

Is NexLife cheaper than Henry Meds?

On a verified all-in basis, NexLife's published price is the one we can confirm; Henry Meds's advertised headline excludes fees, so a definitive cheaper-than claim isn't supportable from our data. Compare all-in where possible.

Why is only NexLife's price called 'all-in'?

Because NexLife publishes the medication-included effective monthly cost across every tier; Henry Meds does not publish a comparable fee-inclusive ladder in our capture.

See the full NexLife review and the provider ranking method.

Not medical advice. This page is consumer education, not medical advice, and does not recommend a dose, product, or provider. Compounded medications are not FDA approved. Talk with a licensed clinician about your situation.